Robin van der Straat

Robin van der Straat is a Researcher in the Medicinal Chemistry, Photopharmacology and Imaging department at the Faculty of Science and Engineering, University of Groningen. Based at A Deusinglaan 1, Building 3211, Room 0462 in Groningen, Netherlands, he contributes to UN Sustainable Development Goals through his work in therapeutic development.

His research focuses on cancer immunotherapy and inflammatory disease modulation, with expertise in designing small-molecule inhibitors targeting immune checkpoints like PD-1/PD-L1 and IL-17a pathways. Key areas include tetrazole derivatives, macrocyclic compounds, and mitochondrial respiration modulators.

Recent publications demonstrate strong trends in structure-based drug design targeting protein-protein interactions, with applications in oncology and autoimmune disorders. His work bridges medicinal chemistry with functional pharmacology, emphasizing translational potential.

Collaborations span international institutions including Jagiellonian University, with co-authorship on datasets related to PD-1/PD-L1 inhibitors. His research network shows significant activity in biochemistry, pharmacology, and molecular biology domains.